Osteoporosis Clinical Trial
Official title:
Prevalence and Determinants of Osteoporosis in Male Veterans
The goals of this project are to establish a new cohort of male veterans and describe associations between potential risk factors and baseline bone mineral density (BMD) as well as rates of BMD loss.
Primary Hypothesis: Risk factors such as smoking, alcohol, and caffeine are associated with
osteoporosis in men.
Intervention: None
Primary Outcomes: Percent reduction in cross-sectional bone mineral density over time.
Study Abstract: The goals of this project are to establish a new cohort of male veterans and
describe associations between potential risk factors and baseline bone mineral density (BMD)
as well as rates of BMD loss.
The study is a two-year observational prospective study of 1000 male veterans aged 50 and
older. The subjects are drawn from two existing VA cohorts, the Normative Aging Study (NAS)
and the Veterans Health Study (VHS). Examinations to be performed on each subject (baseline
and two follow-up exams) include BMD measurement at the hip, forearm and total body,
anthropometry, hand grip strength, and questionnaires on current diet, physical activity,
tobacco, alcohol use, sunlight exposure, health related quality of life (Medical Outcomes
Study Short Form), depression (Brief Depression Scale), fracture history, medications and
psychological factors (PrimeMD, MiniMental). Additional data on historical exposure to risk
factors, previously obtained in the NAS or VHS studies, will also be correlated with BMD and
BMD loss. Multivariate linear and logistic models with control for potential confounders
will be used in the main analyses. Examinations take place at the Boston VA Outpatient
Clinic.
Examinations on each subject include BMD measurement at the hip, forearm and total body,
height and weight, hand grip strength, leg extensor strength, and mobility. Questionnaires
on current diet, physical activity, tobacco, alcohol use, sunlight exposure, health related
quality of life (Medical Outcomes Study Short Form), depression (Brief Depression Scale),
fracture history, medications and psychological factors (PrimeMD, MiniMental) are
administered. Each subject also contributes a nonfasting blood sample and a 24-hour urine
sample.
Beginning in April, 1999, two additional measures are being obtained as a result of a 4-year
supplemental VA Epidemiology grant awarded to Dr. Miller. These are the heel ultrasound
measure and a 4-day physical activity level determined by ambulatory monitor.
Preliminary cross-sectional analysis of mean BMD for femoral neck, total body and forearm
BMD suggest the percent reduction in cross-sectional BMD between ages 60-69 and 80-89 is
approximately 9% per decade at the femoral neck, 5%/decade at the total body, and 8%/decade
at the forearm. These age-related patterns agree well with other studies of BMD in older
men.
The x-ray densitometer was installed at the Boston VA Outpatient Clinic in April, 1998 and
the study technician was certified for bone density measurements during the three-day
training session that followed. A precision study was conducted in the following month. In
vivo reproducibility was determined by performing 5 repeat scans of each of the three sites
on 5 volunteers ranging in age from 21 to 50 years. Subjects were repositioned between each
scan. The coefficient of variation (CV) of femoral neck BMD in our laboratory is 0.92%; for
whole body BMD, 0.72%; and for distal radius BMD, 1.04%. An aluminum spine phantom with
known density (1.254 gm/cm2) is scanned every two weeks on the DPX-IQ. The mean ? standard
deviation of 15 measurements is 1.250 ? 0.0058, coefficient of variation = 0.46%. There has
been no detectable drift in phantom values during the study start-up phase.
When completed, this study will be one of the largest in the US to study risk factors for
osteoporosis in men, historically an understudied group in relation to osteoporosis. Several
of the hypothesized risk factors (smoking, alcohol, caffeine, for example) are amenable to
change and represent potential areas of intervention. Thus, not only can the VA make a
valuable contribution to furthering our understanding of osteoporosis in men in general, but
strategies may be identified to reduce morbidity as well as reduce health care costs
associated with fracture in the elderly.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06287502 -
Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis
|
N/A | |
| Completed |
NCT03822078 -
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
|
Phase 1 | |
| Recruiting |
NCT05845021 -
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
|
N/A | |
| Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
| Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
| Completed |
NCT04736693 -
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
|
||
| Not yet recruiting |
NCT06431867 -
Primary Care Management of Osteoporosis in Older Women
|
||
| Completed |
NCT02922478 -
Role of Comorbidities in Chronic Heart Failure Study
|
||
| Recruiting |
NCT02635022 -
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
|
||
| Recruiting |
NCT02616627 -
Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
|
||
| Active, not recruiting |
NCT02617303 -
Prevention of Falls and Its Consequences in Elderly People
|
N/A | |
| Completed |
NCT02566655 -
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
|
Phase 1 | |
| Completed |
NCT03420716 -
Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women
|
N/A | |
| Not yet recruiting |
NCT02223572 -
Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture
|
N/A | |
| Completed |
NCT02559648 -
Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis
|
Phase 2 | |
| Not yet recruiting |
NCT01854086 -
Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
|
N/A | |
| Completed |
NCT02003716 -
DeFRA Questionnaire as an Anamnestic Form
|
N/A | |
| Unknown status |
NCT01913834 -
Nasally and sc Administered Teriparatide in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT01401556 -
C-STOP Fracture Trial
|
N/A | |
| Completed |
NCT01757340 -
Calorie Restriction With Leucine Supplementation
|
N/A |